At one, three and six-month follow-up, the rate of patients reporting minimal clinically important difference (MCID) in the IIEF-EF score was significantly higher in the treatment group, with 69% achieving MCID six months after PRP versus 27% in the placebo group (p 24 hours), shaving with clippers, and preparation with chlorhexidine-alcohol [570,571]
Contraindications that apply regardless of dose: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Prior serious hypersensitivity to semaglutide Pregnancy or breastfeeding Active pancreatitis or a history of severe pancreatitis Severe gastroparesis Adverse events that can occur at any dose: nausea, vomiting, diarrhea, constipation, abdominal pain, gallbladder disease, acute kidney injury from dehydration, injection-site reactions, and rare cases of pancreatitis
If your plan covers Saxenda or Victoza but not Mounjaro or Zepbound, the out-of-pocket difference may make liraglutide the more practical choice
However, berberine and blood sugar-lowering supplements should be used cautiously due to additive hypoglycemia risk
Everything here is informed speculation for planning purposes
